Figure 1.
Cumulative incidence of response at 12 months post–VST infusion. (A) The cumulative time to best overall response (OR) (either CR or PR) for all patients. (B) The cumulative time to CR for all patients.
Cumulative incidence of response at 12 months post–VST infusion. (A) The cumulative time to best overall response (OR) (either CR or PR) for all patients. (B) The cumulative time to CR for all patients.
